During the hullabaloo surrounding passage of President Obama’s signature piece of legislation, the Patient Protection and Affordable Care Act (aka, Obamacare), proponents extolled the virtues of Canada’s free healthcare system. Critics slammed that same system for its alleged wait times....
Ways to implement the manufacturing and prototyping technology within the pharmaceutical...
In the next few years, regulations will come on line requiring serialized packaging of...
As the Rolling Stones famously said, please allow me to introduce myself. I’m Jason Lomberg, Pharmaceutical Processing’s new Editor. I come to you courtesy of Pharm Pro’s sister pub, Electronic Component News....
Pharmaceutical Processing sat down with Rockwell Automation’s Paula Puess and Khris Kammer to get their take on recent market developments and what the future may hold for the pharmaceutical marketplace.
Pharmaceutical processors face a number of challenges in determining the direction they should take when considering internal investments – but a lack of options have never been amongst them.
Ensuring continuous supplies of near-pure nitrogen to deoxygenate water can be a time-efficient and cost-effective way to formulate today’s medicines.
While it’s a vital link between a facility and the pharmaceuticals shipped in and out every day, the loading dock presents the greatest opportunity for energy losses and damage to precious materials and products.
Shared service management is an important development in the collaboration between an organization’s supporting services, and can make an organization more Lean.
Downstream processing continues to impact capacity at the majority of biopharmaceutical manufacturing facilities.
Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.
Get a taste of the year’s biggest event for pharmaceutical and biotechnology professionals with six pages of our Interphex Exhibitor Highlights. Page till the end to preview a schedule of convention workshops and events.
The globalization of the pharmaceutical industry means inspection and identification of incoming raw materials is more important than ever. While this could mean a hiccup in the production process, we give you a case study of how handheld Raman technology meant an opportunity for cost savings.
Optimal efficiency means that your Contract Management, Rebate Processing, and Government pricing teams have to not only communicate, they have to collaborate. Lois Byra from Alliance Life Sciences Consulting Group walks us through what it means to transform silos into synergy.
Enteris BioPharma seeks to stand out from a pack of contract manufacturers with experience, flexibility, and quality. While much of market is focused on mammalian cell cultures, Enteris has “carved out their own niche” in microbial expression systems.
On the one hand, the drug manufacturing industry is expanding, with an increase in global imports and exports. On the other hand however, the drug manufacturing industry is becoming more specialized.
Thanks for sparing some time in your busy day to visit our site or check out one of our daily newsletters. In respect to that dynamic, I’ll be brief in sharing some of the new things we’re doing to improve the daily content mix.